| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3216319
Max Phase: Preclinical
Molecular Formula: C24H52Cl2N2O4
Molecular Weight: 430.67
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCCCCN[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1NCCCCCCCCC.Cl.Cl
Standard InChI: InChI=1S/C24H50N2O4.2ClH/c1-3-5-7-9-11-13-15-17-25-19-20(22(28)24(30)23(29)21(19)27)26-18-16-14-12-10-8-6-4-2;;/h19-30H,3-18H2,1-2H3;2*1H/t19-,20+,21-,22-,23+,24+;;/m0../s1
Standard InChI Key: VPYGDXYSDSDCCM-OPUMXUIRSA-N
Associated Targets(Human)
Beta-glucocerebrosidase 14647 Activities
Ceramide glucosyltransferase 308 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Beta-galactosidase 500 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Alpha-galactosidase 362 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 430.67 | Molecular Weight (Monoisotopic): 430.3771 | AlogP: 2.86 | #Rotatable Bonds: 18 |
| Polar Surface Area: 104.98 | Molecular Species: BASE | HBA: 6 | HBD: 6 |
| #RO5 Violations: 1 | HBA (Lipinski): 6 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 12.65 | CX Basic pKa: 8.65 | CX LogP: 3.96 | CX LogD: 2.68 |
| Aromatic Rings: 0 | Heavy Atoms: 30 | QED Weighted: 0.19 | Np Likeness Score: 0.45 |
References
| 1. Trapero A, Llebaria A.. (2011) The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease., 2 (8): [PMID:24900357] [10.1021/ml200098j] |
Source
Source(1):